Zentek (NASDAQ:ZTEK) Stock Price Up 0.9%

Shares of Zentek Ltd. (NASDAQ:ZTEK) shot up 0.9% during trading on Tuesday . The stock traded as high as $1.15 and last traded at $1.12. 15,226 shares were traded during mid-day trading, a decline of 29% from the average session volume of 21,308 shares. The stock had previously closed at $1.11.

Zentek Price Performance

The company has a market cap of $112.92 million, a price-to-earnings ratio of -16.00 and a beta of 0.63. The company has a current ratio of 6.05, a quick ratio of 4.27 and a debt-to-equity ratio of 0.03. The company’s 50 day moving average price is $1.21 and its 200 day moving average price is $1.21.

Zentek (NASDAQ:ZTEK) last released its earnings results on Monday, February 12th. The company reported ($0.02) EPS for the quarter. The firm had revenue of $0.01 million for the quarter.

Institutional Trading of Zentek

A hedge fund recently raised its stake in Zentek stock. Scotia Capital Inc. increased its stake in Zentek Ltd. (NASDAQ:ZTEK) by 2.7% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 450,220 shares of the company’s stock after purchasing an additional 11,924 shares during the quarter. Scotia Capital Inc. owned 0.45% of Zentek worth $567,000 at the end of the most recent quarter. Institutional investors own 0.77% of the company’s stock.

About Zentek

Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound.